                         SEQUENCE LISTING

<110>  BRISTOL-MYERS SQUIBB COMPANY
 
<120>  CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS

<130>  12998-US-NP

<150>  US62/538,329
<151>  2017-07-28

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  210
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Homosapien

<400>  1

Met Gly Ser Ser His His His His His His Ser Ser Gly Glu Thr Val 
1               5                   10                  15      


Arg Phe Gln Gly His Met Ser Val Ala His Gly Leu Ala Trp Ser Tyr 
            20                  25                  30          


Tyr Ile Gly Tyr Leu Arg Leu Ile Leu Pro Glu Leu Gln Ala Arg Ile 
        35                  40                  45              


Arg Thr Tyr Asn Gln His Tyr Asn Asn Leu Leu Arg Gly Ala Val Ser 
    50                  55                  60                  


Gln Arg Leu Tyr Ile Leu Leu Pro Leu Asp Cys Gly Val Pro Asp Asn 
65                  70                  75                  80  


Leu Ser Met Ala Asp Pro Asn Ile Arg Phe Leu Asp Lys Leu Pro Gln 
                85                  90                  95      


Gln Thr Gly Asp Arg Ala Gly Ile Lys Asp Arg Val Tyr Ser Asn Ser 
            100                 105                 110         


Ile Tyr Glu Leu Leu Glu Asn Gly Gln Arg Ala Gly Thr Cys Val Leu 
        115                 120                 125             


Glu Tyr Ala Thr Pro Leu Gln Thr Leu Phe Ala Met Ser Gln Tyr Ser 
    130                 135                 140                 


Gln Ala Gly Phe Ser Arg Glu Asp Arg Leu Glu Gln Ala Lys Leu Phe 
145                 150                 155                 160 


Cys Arg Thr Leu Glu Asp Ile Leu Ala Asp Ala Pro Glu Ser Gln Asn 
                165                 170                 175     


Asn Cys Arg Leu Ile Ala Tyr Gln Glu Pro Ala Asp Asp Ser Ser Phe 
            180                 185                 190         


Ser Leu Ser Gln Glu Val Leu Arg His Leu Arg Gln Glu Glu Lys Glu 
        195                 200                 205             


Glu Val 
    210 


<210>  2
<211>  210
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Homosapien

<400>  2

Met Gly Ser Ser His His His His His His Ser Ser Gly Glu Thr Val 
1               5                   10                  15      


Arg Phe Gln Gly His Met Ser Val Ala His Gly Leu Ala Trp Ser Tyr 
            20                  25                  30          


Tyr Ile Gly Tyr Leu Arg Leu Ile Leu Pro Glu Leu Gln Ala Arg Ile 
        35                  40                  45              


Arg Thr Tyr Asn Gln His Tyr Asn Asn Leu Leu Arg Gly Ala Val Ser 
    50                  55                  60                  


Gln Arg Leu Tyr Ile Leu Leu Pro Leu Asp Cys Gly Val Pro Asp Asn 
65                  70                  75                  80  


Leu Ser Met Ala Asp Pro Asn Ile Arg Phe Leu Asp Lys Leu Pro Gln 
                85                  90                  95      


Gln Thr Ala Asp Arg Ala Gly Ile Lys Asp Arg Val Tyr Ser Asn Ser 
            100                 105                 110         


Ile Tyr Glu Leu Leu Glu Asn Gly Gln Arg Ala Gly Thr Cys Val Leu 
        115                 120                 125             


Glu Tyr Ala Thr Pro Leu Gln Thr Leu Phe Ala Met Ser Gln Tyr Ser 
    130                 135                 140                 


Gln Ala Gly Phe Ser Arg Glu Asp Arg Leu Glu Gln Ala Lys Leu Phe 
145                 150                 155                 160 


Cys Gln Thr Leu Glu Asp Ile Leu Ala Asp Ala Pro Glu Ser Gln Asn 
                165                 170                 175     


Asn Cys Arg Leu Ile Ala Tyr Gln Glu Pro Ala Asp Asp Ser Ser Phe 
            180                 185                 190         


Ser Leu Ser Gln Glu Val Leu Arg His Leu Arg Gln Glu Glu Lys Glu 
        195                 200                 205             


Glu Val 
    210 


